VolitionRx's (VNRX) CEO Cameron Reynolds on Q2 2020 Results - Earnings Call Transcript

VolitionRx Limited (NYSE:VNRX) Q2 2020 Earnings Conference Call August 14, 2020 8:30 AM ET

Company Participants

Scott Powell – Executive Vice President-Investor Relations
Cameron Reynolds – President and Chief Executive Officer

Conference Call Participants

Mike Okunewitch – Maxim Group
Mark Briedenbach – Oppenheimer & Company
Bruce Jackson – The Benchmark Company
Nathan Weinstein – Aegis Capital
Steven Ralston – Zacks

Operator

Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the VolitionRx Limited’s Second Quarter 2020 Earnings Conference Call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be opened for questions. [Operator Instructions] This conference call is being recorded, August 14, 2020.

I’d now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.

Scott Powell

Thank you, and welcome everyone to today’s earnings conference call for VolitionRx Limited. This call will cover Volition’s financial and operating results for the second quarter of 2020, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session. Also on our call today is Mr. Cameron Reynolds, President and Chief Executive Officer; and Mr. David Vanston, Chief Financial Officer.

Before we begin, I’d like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions.

Actual future results may vary significantly based on a number of factors